title: Nuclear cardiology, Part IV: Viability.
abstract: After reading Part IV of this series of nuclear cardiology articles, the reader should be able to describe: (a) the differences between SPECT and PET techniques; (b) the various radiopharmaceuticals and imaging protocols used for detecting viability with SPECT; (c) the different radiopharmaceuticals and imaging protocols used for detecting viability with PET; and (d) the imaging patterns observed after reconstructing myocardial images.
authors.affiliation: Catholic University of Leuven, Belgium.
authors.forename: L
authors.initials: L
authors.lastname: Mesotten
authors.forename: A
authors.initials: A
authors.lastname: Maes
authors.forename: A S
authors.initials: AS
authors.lastname: Hambye
authors.forename: H
authors.initials: H
authors.lastname: Everaert
authors.forename: V
authors.initials: V
authors.lastname: Van den Maegdenbergh
authors.forename: P
authors.initials: P
authors.lastname: Franken
authors.forename: L
authors.initials: L
authors.lastname: Mortelmans
mesh_terms: D003327:Coronary Disease / Q000000981:diagnostic imaging*; D006321:Heart / Q000000981:diagnostic imaging; D006801:Humans; D017682:Myocardial Stunning / Q000000981:diagnostic imaging*; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging*
chemical_list: D019275:Radiopharmaceuticals